ZAGREB, March 28 (Hina) - The response of foreign investors to
purchase shares of the Croatian pharmaceutical company "Pliva" was
beyond all expectations, Zagrebacka Banka said in a statement on
Thursday.
The most respectable and best international investors and
banks had shown an interest in Pliva's shares which largely
exceeded the supply, the statement said.
The price of Pliva's shares was set in London on Thursday,
with one share being sold at 5,100 kuna or DM 1,378.
The value of Pliva's shares was expected to grow with trading
on the secondary market, scheduled to begin on April 11.
This was the first Croatian company whose shares were verified
by the international capital market.
Zagrebacka Banka said it had decided to extend a bid for
purchase of Pliva's shares on the domestic market for another three
days, until March 30.
(hina) vm jn
281851 MET mar 96
Američki diplomati protestiraju: Rezanje pomoći inozemstvu umanjuje moć SAD-a
Majdak: Sigurnost hrane mora ostati dio strateške autonomije EU-a
Čak 200.000 prijava za maraton u New Yoku
LP mladih: AZ Alkmaar ponovno koban za Real Madrid
Božinović: Vraćanje nelegalnih migranata više nije tabu tema u EU-u
Skijaški skokovi: Zlato za norvešku mješanu ekipu
BBŽ isplaćuje putne troškove pacijentima kojima je HZZO odbio naknade
SAD tajno pregovara s Hamasom o puštanju talaca u Gazi - izvor
Slijepčević: "Uspjeh filmova nije samo u nagradama"
Najava - gospodarstvo - za četvrtak, 6. ožujka